Amreen Dinani | Scholars@Duke

Amreen Dinani
Associate Professor of Medicine

I see patients with chronic liver diseases. I have a clinical and research interest in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Areas of interest include identifying patients at high risk for NAFLD/NASH, developing care pathways to specialty care and creating sustainable multidisciplinary and lifestyle programs for people impacted with NAFLD/NASH.

Current Appointments & Affiliations

Associate Professor of Medicine, Medicine, Gastroenterology, Medicine 2023

Contact Information

40 Medicine Circle, Durham, NC 27710
amreen.dinani@duke.edu

Background
Education, Training, & Certifications
- Fellowship, Gastroenterology, McMaster University (Canada) 2011 - 2013
- Fellowship, Clinical Hepatology, University of Toronto (Canada) 2010 - 2011
- Clinical Research Assistant, Inflammatory Bowel Disease, University of Toronto (Canada) 2009 - 2010
- Residency, Internal Medicine, New York Presbyterian Hospital 2006 - 2009
- M.D., American University of the Caribbean 2005
Previous Appointments & Affiliations
- Instructor in the Department of Medicine, Medicine, Gastroenterology, Medicine 2022
Expertise
Subject Headings
Research
Selected Grants
- Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis awarded by National Institutes of Health 2021 - 2026
External Relationships
- Guidepoint Clinical
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Ma, Ning, Rowena Yip, Sara Lewis, Amreen Dinani, Christina Wyatt, Michael Crane, Artit Jirapatnakul, et al. “Environmental exposures are important risk factors for advanced liver fibrosis in African American adults.” Jhep Rep 5, no. 4 (April 2023): 100696. https://doi.org/10.1016/j.jhepr.2023.100696.
    Full Text Link to Item
  - Nathani, Rohit, Randy Leibowitz, Dewan Giri, Carolina Villarroel, Sidra Salman, Mantej Sehmbhi, Bo Hyung Yoon, Amreen Dinani, and Ilan Weisberg. “The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection.” J Viral Hepat 30, no. 3 (March 2023): 195–200. https://doi.org/10.1111/jvh.13779.
    Full Text Link to Item
  - Talal, Andrew H., Amreen Dinani, and Lawrence S. Brown. “Hepatitis C Virus Treatment Delivered via Telemedicine to Persons With Opioid Use Disorder.” Jama Intern Med 182, no. 9 (September 1, 2022): 1011. https://doi.org/10.1001/jamainternmed.2022.2566.
    Full Text Link to Item
  - Hershman, M., K. Torbjornsen, D. Pang, B. Wyatt, D. T. Dieterich, P. V. Perumalswami, A. D. Branch, and A. M. Dinani. “Modification of the diabetes prevention program for the treatment of nonalcoholic fatty liver disease: A pilot study.” Obesity Science and Practice, January 1, 2022. https://doi.org/10.1002/osp4.637.
    Full Text
  - Talal, Andrew H., Marianthi Markatou, Elisavet M. Sofikitou, Lawrence S. Brown, Ponni Perumalswami, Amreen Dinani, and Jonathan N. Tobin. “Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).” Contemp Clin Trials 112 (January 2022): 106632. https://doi.org/10.1016/j.cct.2021.106632.
    Full Text Link to Item
  - Wyatt, Brooke, Ponni V. Perumalswami, Anna Mageras, Mark Miller, Alyson Harty, Ning Ma, Chip A. Bowman, et al. “A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure.” Hepatology 74, no. 6 (December 2021): 2974–87. https://doi.org/10.1002/hep.32086.
    Full Text Link to Item
  - Dinani, Amreen M., Kris V. Kowdley, and Mazen Noureddin. “Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art.” Hepatology (Baltimore, Md.) 74, no. 4 (October 2021): 2233–40. https://doi.org/10.1002/hep.31869.
    Full Text
  - Talal, Andrew H., Urmo Jaanimägi, Kathleen Davis, Jordan Bailey, Barbara M. Bauer, Arpan Dharia, Saliyah George, et al. “Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers.” J Subst Abuse Treat 127 (August 2021): 108421. https://doi.org/10.1016/j.jsat.2021.108421.
    Full Text Link to Item
  - Wu, Yi Chia, Philip M. Chuang, Rachel Pinotti, Ankita Nagirimadugu, Nelson Valentin, and Amreen Dinani. “The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review.” Eur J Gastroenterol Hepatol 33, no. 5 (May 1, 2021): 745–51. https://doi.org/10.1097/MEG.0000000000001967.
    Full Text Link to Item
  - Cowan, Ethan A., Amreen Dinani, Samantha Brandspiegel, Clare O’Brien-Lambert, Joseph Zaheer, Erick Eiting, George Loo, and Yvette Calderon. “Nontargeted Hepatitis C Screening in an Urban Emergency Department in New York City.” J Emerg Med 60, no. 3 (March 2021): 299–309. https://doi.org/10.1016/j.jemermed.2020.09.034.
    Full Text Link to Item
  - Asgharpour, A., A. Dinani, and S. L. Friedman. “Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: Collaboration with industry.” Translational Gastroenterology and Hepatology 6 (January 21, 2021). https://doi.org/10.21037/TGH.2020.01.04.
    Full Text
  - Dinani, A., A. Khan, and D. Dieterich. “Emerging prevalence of fatty liver disease in HIV.” Future Virology 16, no. 1 (January 1, 2021): 59–73. https://doi.org/10.2217/fvl-2020-0184.
    Full Text
  - Dinani, A. M., S. Lewis, A. D. Branch, and P. Perumalswami. “Working Up an Incidental Finding of Hepatic Steatosis on Imaging.” Clinical Liver Disease 16, no. 2 (August 1, 2020): 58–62. https://doi.org/10.1002/cld.926.
    Full Text
  - Esteban, J. P., and A. Dinani. “Lifestyle interventions beyond diet and exercise for patients with nonalcoholic fatty liver disease.” Gastroenterology and Hepatology 16, no. 3 (March 1, 2020): 119–30.
  - Puigvehí, Marc, Dana Hashim, Philipp K. Haber, Amreen Dinani, Thomas D. Schiano, Amon Asgharpour, Tatyana Kushner, et al. “Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.” Am J Transplant 20, no. 1 (January 2020): 220–30. https://doi.org/10.1111/ajt.15576.
    Full Text Link to Item
  - Dinani, A., and A. Sanyal. “Nonalcoholic fatty liver disease: Implications for cardiovascular risk.” Cardiovascular Endocrinology 6, no. 2 (January 1, 2017): 62–72. https://doi.org/10.1097/XCE.0000000000000126.
    Full Text
  - Sampath, Kartik, Amreen M. Dinani, and Richard I. Rothstein. “Endoscopic Devices for Obesity.” Curr Obes Rep 5, no. 2 (June 2016): 251–61. https://doi.org/10.1007/s13679-016-0217-8.
    Full Text Link to Item
  - Waterman, Matti, Jo Knight, Amreen Dinani, Wei Xu, Joanne M. Stempak, Kenneth Croitoru, Geoffrey C. Nguyen, et al. “Predictors of Outcome in Ulcerative Colitis.” Inflamm Bowel Dis 21, no. 9 (September 2015): 2097–2105. https://doi.org/10.1097/MIB.0000000000000466.
    Full Text Link to Item
  - Waterman, Matti, Wei Xu, Amreen Dinani, A Hillary Steinhart, Kenneth Croitoru, Geoffrey C. Nguyen, Robin S. McLeod, Gordon R. Greenberg, Zane Cohen, and Mark S. Silverberg. “Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease.” Gut 62, no. 3 (March 2013): 387–94. https://doi.org/10.1136/gutjnl-2011-301495.
    Full Text Link to Item
  - Dinani, Amreen M., Sandra E. Fischer, Jeff Mosko, Maha Guindi, and Gideon M. Hirschfield. “Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis.” Clin Gastroenterol Hepatol 10, no. 6 (June 2012): 682–84. https://doi.org/10.1016/j.cgh.2012.02.010.
    Full Text Link to Item
  - Dinani, A., C. Urban, R. Colon-Urban, and W. Wehbeh. “Community-acquired multi-drug resistant Escherichia coli in a patient presenting with pyelonephritis.” Infectious Diseases in Clinical Practice 19, no. 1 (January 1, 2011): 59–60. https://doi.org/10.1097/IPC.0b013e3181e928bc.
    Full Text
  - Nguyen, Geoffrey C., Amreen M. Dinani, and Kevin Pivovarov. “Endoscopic management and outcomes of pregnant women hospitalized for nonvariceal upper GI bleeding: a nationwide analysis.” Gastrointest Endosc 72, no. 5 (November 2010): 954–59. https://doi.org/10.1016/j.gie.2010.07.018.
    Full Text Link to Item
  - Basu, P. P., A. Dinani, K. Rayapudi, T. Pacana, N. J. Shah, H. Hampole, N. V. Krishnaswamy, and V. Mohan. “Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: A prospective pilot trial.” Therapeutic Advances in Gastroenterology 3, no. 4 (January 1, 2010): 221–25. https://doi.org/10.1177/1756283X10372985.
    Full Text
  - Dinani, Amreen, Nessrine Ktaich, Carl Urban, and David Rubin. “Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis.” J Med Microbiol 58, no. Pt 10 (October 2009): 1385–87. https://doi.org/10.1099/jmm.0.012658-0.
    Full Text Link to Item
  - Dinani, A. M., R. A. Cortes, S. Sridhara, S. Reichert, and K. Somnay. “Retrieval of a migrated Polyflex stent--a novel technique.” Endoscopy 41 Suppl 2 (2009): E304–5. https://doi.org/10.1055/s-0029-1215001.
    Full Text Link to Item
- Conference Papers
  - Karim, Gres, Nour Al Khalili, Minira Aslanova, Dewan Giri, Amreen Dinani, and Ilan Weisberg. “COVID-19 Vaccine-Induced Liver Injury: A Case Series.” In American Journal of Gastroenterology, 117:S1892–93, 2022.
    Link to Item
  - Khazak, Andre, Carolina Villarroel, Silpa Yarra, Minira Aslanova, and Amreen Dinani. “Small Cell Neuroendocrine Carcinoma of the Esophagus Presenting as Acute Hematemesis.” In American Journal of Gastroenterology, 117:S1594–95, 2022.
    Link to Item
  - Shenoy, Shabari M., Gres Karim, Shanique W. Noack, Joshua Safer, Ilan Weisberg, and Amreen Dinani. “The Impact of Social Determinants of Health on Colorectal Cancer Screening in Transgender People.” In American Journal of Gastroenterology, 117:S215–16, 2022.
    Link to Item
  - Dinani, Amreen, Amit Desai, Nina Kohn, Ellen Gutkin, Michel Nussbaum, and Kaumudi Somnay. “High rates of advanced gastric cancer in community of Flushing, New York.” In J Gastrointest Cancer, 43:44–49, 2012. https://doi.org/10.1007/s12029-010-9191-7.
    Full Text Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Previous Appointments & Affiliations

Subject Headings

Selected Grants

External Relationships

Selected Publications

Academic Articles

Conference Papers